Abstract | UNLABELLED: What's known on the subject? and What does the study add? Pervasive inflammatory infiltrates, mainly composed of chronically activated T cells and monocytes/macrophages, have been observed in benign prostatic hyperplasia (BPH). Permixon®, a hexanic lipidosterolic extract of Serenoa repens (hexanic LSESr) used to treat urinary dysfunction in BPH patients, has anti-inflammatory activities. This paper provides new insights into the anti-inflammatory properties of Permixon®. We report that hexanic LSESr inhibits early steps of leukocyte infiltration in vitro by downregulating MCP-1/CCL2 and VCAM-1 expression. OBJECTIVE: MATERIALS AND METHODS: After pretreatment with hexanic LSESr, human prostate (epithelial and myofibroblastic) cells and vascular endothelial cells were stimulated with proinflammatory cytokines. MCP-1/CCL2 and VCAM-1 mRNA expression was quantified by real-time PCR. ELISA kits were used to determine MCP-1/CCL2 levels in culture supernatants and VCAM-1 expression in living cells. RESULTS: Hexanic LSESr reduced MCP-1/CCL2 mRNA levels in both epithelial (BPH-1) and myofibroblastic (WPMY-1) prostate cell lines. Hexanic LSESr downregulated MCP1/CCL2 secretion by WPMY-1 cells in a concentration-dependent manner, more efficiently than Serenoa repens extracts obtained by supercritical carbon dioxide extraction. Hexanic LSESr inhibited tumour- necrosis-factor-α-induced MCP-1/CCL2 secretion by the human vascular endothelial cell line EAhy.926, as well as surface VCAM-1 protein expression, in a concentration-dependent manner. CONCLUSIONS: Hexanic LSESr impedes key steps of monocyte and T cell attraction and adherence by inhibiting MCP-1/CCL2 and VCAM-1 expression by human prostate and vascular cells in an inflammatory environment. These findings provide new insights into the anti-inflammatory effects of the hexanic lipidosterolic extract of Serenoa repens, Permixon®, in benign prostatic hyperplasia.
|
Authors | Alain Latil, Christine Libon, Marie Templier, Didier Junquero, Frédérique Lantoine-Adam, Thien Nguyen |
Journal | BJU international
(BJU Int)
Vol. 110
Issue 6 Pt B
Pg. E301-7
(Sep 2012)
ISSN: 1464-410X [Electronic] England |
PMID | 22520557
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2012 BJU INTERNATIONAL. |
Chemical References |
- Chemokine CCL2
- Hexanes
- Plant Extracts
- Vascular Cell Adhesion Molecule-1
|
Topics |
- Cells, Cultured
- Chemokine CCL2
(antagonists & inhibitors, biosynthesis)
- Hexanes
(pharmacology)
- Humans
- Plant Extracts
(pharmacology)
- Serenoa
- Vascular Cell Adhesion Molecule-1
(biosynthesis, drug effects)
|